| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |